Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients.

Wang JL, Lai CH, Lin HH, Chen WF, Shih YC, Hung CH.

Int J Antimicrob Agents. 2013 Nov;42(5):390-4. doi: 10.1016/j.ijantimicag.2013.07.010. Epub 2013 Aug 23.

PMID:
24041465
[PubMed - indexed for MEDLINE]
2.

Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.

Park KH, Kim ES, Kim HS, Park SJ, Bang KM, Park HJ, Park SY, Moon SM, Chong YP, Kim SH, Lee SO, Choi SH, Jeong JY, Kim MN, Woo JH, Kim YS.

J Antimicrob Chemother. 2012 Aug;67(8):1843-9. doi: 10.1093/jac/dks131. Epub 2012 Apr 25.

PMID:
22535621
[PubMed - indexed for MEDLINE]
Free Article
3.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

PMID:
21525024
[PubMed - indexed for MEDLINE]
Free Article
4.

Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.

Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R.

J Clin Microbiol. 2009 Jun;47(6):1640-4. doi: 10.1128/JCM.02135-08. Epub 2009 Apr 15.

PMID:
19369444
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565
[PubMed - indexed for MEDLINE]
6.

Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR.

Clin Infect Dis. 2012 Nov 15;55(10):1329-37. doi: 10.1093/cid/cis717. Epub 2012 Aug 20.

PMID:
22911641
[PubMed - indexed for MEDLINE]
Free Article
7.

Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.

Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V.

BMC Infect Dis. 2013 Dec 10;13:583. doi: 10.1186/1471-2334-13-583.

PMID:
24325260
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR.

J Antimicrob Chemother. 2014 Jan;69(1):211-8. doi: 10.1093/jac/dkt340. Epub 2013 Aug 29.

PMID:
23997017
[PubMed - indexed for MEDLINE]
9.

Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.

Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.

Int J Antimicrob Agents. 2014 Feb;43(2):179-83. doi: 10.1016/j.ijantimicag.2013.10.017. Epub 2013 Nov 18.

PMID:
24315788
[PubMed - indexed for MEDLINE]
10.

Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.

van Hal SJ, Jones M, Gosbell IB, Paterson DL.

PLoS One. 2011;6(6):e21217. doi: 10.1371/journal.pone.0021217. Epub 2011 Jun 21.

PMID:
21713004
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.

Lin SY, Chen TC, Chen FJ, Chen YH, Lin YI, Siu LK, Lu PL.

J Microbiol Immunol Infect. 2012 Dec;45(6):435-41. doi: 10.1016/j.jmii.2012.05.004. Epub 2012 Jun 30.

PMID:
22749725
[PubMed - indexed for MEDLINE]
12.

Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.

Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Ishikawa T, Tamura K, Tsuji BT.

Scand J Infect Dis. 2013 Mar;45(3):203-12. doi: 10.3109/00365548.2012.723221. Epub 2012 Oct 31.

PMID:
23113753
[PubMed - indexed for MEDLINE]
13.

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.

Sader HS, Jones RN, Rossi KL, Rybak MJ.

J Antimicrob Chemother. 2009 Nov;64(5):1024-8. doi: 10.1093/jac/dkp319. Epub 2009 Sep 10.

PMID:
19744978
[PubMed - indexed for MEDLINE]
Free Article
14.

Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.

Kan LP, Lin JC, Chiu SK, Yeh YC, Lin TY, Yang YS, Wang YC, Wang NC, Yeh KM, Chang FY.

J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.

PMID:
23040238
[PubMed - indexed for MEDLINE]
15.

Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.

Hope R, Blackburn RM, Verlander NQ, Johnson AP, Kearns A, Hill R, Hopkins S, Sheridan E, Livermore DM; Vancomycin Outcome Study Group; UK Clinical Infection Research Group.

J Antimicrob Chemother. 2013 Nov;68(11):2641-7. doi: 10.1093/jac/dkt234. Epub 2013 Jun 21.

PMID:
23794604
[PubMed - indexed for MEDLINE]
Free Article
16.

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.

Honda H, Doern CD, Michael-Dunne W Jr, Warren DK.

BMC Infect Dis. 2011 Dec 5;11:335. doi: 10.1186/1471-2334-11-335.

PMID:
22142287
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).

Gould IM.

Int J Antimicrob Agents. 2013 Jun;42 Suppl:S17-21. doi: 10.1016/j.ijantimicag.2013.04.006. Epub 2013 May 8. Review.

PMID:
23664580
[PubMed - indexed for MEDLINE]
18.

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G.

J Infect Dis. 2009 Mar 1;199(5):619-24. doi: 10.1086/596629.

PMID:
19199552
[PubMed - indexed for MEDLINE]
Free Article
19.

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.

Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ.

J Antimicrob Chemother. 2010 May;65(5):1015-8. doi: 10.1093/jac/dkq050. Epub 2010 Mar 3.

PMID:
20200036
[PubMed - indexed for MEDLINE]
Free Article
20.

Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.

Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM.

J Clin Microbiol. 2011 Jan;49(1):269-74. doi: 10.1128/JCM.00914-10. Epub 2010 Oct 20.

PMID:
20962147
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk